Manufacturing

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API) manufacturing facility at Jinshan (Shanghai, China) has…
Read More...

WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully. This 200,000 sq. ft. newly completed state-of-the-art clinical manufacturing…
Read More...

MEDISCA announced the launch of SAMIX Systems, a new line of highly reliable and versatile compounding systems for efficient mixing. Through this partnership, MEDISCA will be the…
Read More...

Pfizer announced it will increase its commitment to U.S. manufacturing with a $465 million investment to build one of the most technically advanced sterile injectable pharmaceutical…
Read More...

Cambrex Corporation announced it has entered into a definitive agreement to acquire Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO),…
Read More...

Sterigenics announced that it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to…
Read More...

Cryoport announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport's full suite of temperature-controlled solutions into its global network. This integrated…
Read More...

Catalent Pharma Solutions and Berkeley Lights announced Catalent Biologics will adopt BLI’s Beacon optofluidic platform to accelerate its cell line development workflow. The Beacon…
Read More...

ProBioGen AG and Pionyr Immunotherapeutics announced a second service and license agreement to develop novel antibody therapeutics. Under the terms of the agreement, ProBioGen will…
Read More...

International Stem Cell Corporation, a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced that its…
Read More...

Recipharm has announced the launch of its standalone serialisation service ahead of the introduction of the EU Falsified Medicines Directive (FMD). The new service is designed to…
Read More...

Shire plc announced that the United States Food and Drug Administration (FDA) has approved the company's first submission for its new plasma manufacturing facility near Covington,…
Read More...

WuXi Biologics and Harbour BioMed announced an initial strategic collaboration for the development and manufacturing of Harbour's leading HCAb antibody. The collaboration with WuXi…
Read More...

MeiraGTx announced it has been granted a Manufacturer’s Authorization for Investigational Medicinal Products from the United Kingdom’s Medicines and Healthcare products Regulatory…
Read More...

Cambrex Corporation announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150m²…
Read More...

Avara Pharmaceutical Services announced that it has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical…
Read More...

Samsung BioLogics announced that a third monoclonal antibody Drug Substance has been licensed by the US FDA (Food and Drug Administration) for its second plant, the world's largest…
Read More...

mAbxience, a company specialized in the research, development, manufacturing and global commercialization of monoclonal antibody biosimilars, part of the Insud Pharma Group and Amneal…
Read More...

TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc. DORA Ventures is a newly formed investment…
Read More...

Catalent Pharma Solutions and Valerius Biopharma AG announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar products. Under the agreement,…
Read More...